A comeback is underway for psychedelics. Scientists, investors, and consumers alike are intrigued by the therapeutic potential of psilocybin mushrooms in particular. The burgeoning cannabis industry has sparked the interest of the psilocybin market. Could we be on the verge of a psilocybin boom?

Psilocybin Mushrooms

A mushroom containing the psychoactive compound psilocybin is called a mushroom or “magic mushroom.” Indigenous cultures have used psychedelic substances like psilocybin for healing and spiritual purposes for centuries.  As a result of their psychedelic effects, shrooms can produce powerful changes in perception, mood, and cognition. Most trips last about six hours.

Shrooms: Why do we need them?

The scientific community is finally exploring the therapeutic potential of psychedelics after decades of regulatory barriers.

There is mounting evidence that psilocybin may be helpful in treating a range of mental health conditions, including depression, anxiety, and addiction.(1)

Investors are taking note of this renaissance in psychedelic research. There have been several psychedelic-focused startups born in the past few years and investments have risen. (2)

Psilocybin is even decriminalised in some cities – like Denver, Oakland, and Washington, DC. The state of Oregon has even taken it further with Measure 109, which will make psilocybin therapy legal for adults 21+ by 2023.

In a world where laws are constantly evolving, it’s not out of the realm of possibility that psilocybin mushrooms will become as common as cannabis in the future.

A consumer profile of psilocybin

In a recent study by Brightfield Group, mental health was identified as one of the most important reasons people consume magic mushrooms(4).

Many mushroom users report using mushrooms to treat depression and PTSD, while Gen Xers and millennials report using them to treat PTSD. The popularity of mushrooms is also attributed to their recreational and spiritual uses. Psilocybin’s mental health potential is gaining traction as the stigma surrounding psychedelics dissipates.

There seems to be an increased interest in trying mushrooms than ever before. In addition to 20% of non-mushroom eaters who will use it “definitely,” 21% are considering it.

The Power Couple of Cannabis & Mushrooms?

There is a higher rate of cannabis use among psilocybin users than among the general population, with 35% of surveyed mushroom users reporting past-year cannabis use.

In addition to altering perception, both substances boost mood. There are two forms of psilocybin that provide relaxation and euphoria.(2) But psilocybin typically has a stronger effect. Any companies interested in jumping into the psilocybin market could benefit from tapping into the cannabis market.

More (sh)room is always available

The psychedelic revolution is just around the corner, are we not? We’ll have to wait and see.

There might be an increase in demand for magic mushrooms as public awareness of psilocybin’s therapeutic potential increases. Additionally, with cannabis users more likely to use psilocybin mushrooms, it is possible that we will see markets collide in the near future.

CBD Crash Due To ShroomBoom?

Magic mushroom users often choose CBD over high-THC cannabis because of its non-psychoactive properties. But why choose CBD over high-THC cannabis? Reasons for this include:

There may be a reason why users of psilocybin mushrooms don’t want to intensify their psychedelic experience.

CBD is not addictive like THC.

Due to its non-intoxicating nature, CBD can be used on a regular basis (daily, all day long).

Mushrooms can cause nausea and anxiety, but CBD may reduce these effects.

The combination of cannabis, CBD, and mushrooms makes sense.

Related Blog:

Leave a Comment